Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 86.14 | 79.70 | 95.84 | 44.23 |
Depreciation/ Depletion | 17.02 | 22.28 | 18.93 | 16.31 |
Non- Cash Items | 17.13 | 7.36 | 4.25 | 14.48 |
Changesin Working Capital | -127.74 | -135.93 | -12.78 | 14.05 |
Cashfrom Operating Activities | -7.46 | -26.59 | 106.24 | 89.06 |
Capital Expenditures | -112.69 | -187.60 | -87.45 | -14.21 |
Other Investing Cash Flow Items Total | 10.31 | -3.13 | -7.14 | 5.71 |
Cashfrom Investing Activities | -102.39 | -190.73 | -94.59 | -8.51 |
Financing Cash Flow Items | -15.24 | -8.12 | -5.03 | -13.42 |
Total Cash Dividends Paid | -0.97 | -1.04 | -0.92 | -0.36 |
Issuance( Retirement)of Stock Net | 99.99 | - | - | - |
Issuance( Retirement)of Debt Net | -1.40 | 243.47 | -0.29 | -64.84 |
Cashfrom Financing Activities | 82.38 | 234.31 | -6.24 | -78.62 |
Net Changein Cash | -27.47 | 16.99 | 5.41 | 1.94 |
Cash Interest Paid | 14.68 | 7.91 | 4.81 | 13.42 |
Cash Taxes Paid | 27.04 | 27.70 | 33.06 | 9.40 |
Gufic Biosciences Dividend Gufic Biosciences Bonus Gufic Biosciences News Gufic Biosciences AGM Gufic Biosciences Rights Gufic Biosciences Splits Gufic Biosciences Board Meetings Gufic Biosciences Key Metrics Gufic Biosciences Shareholdings Gufic Biosciences Profit Loss Gufic Biosciences Balance Sheet Gufic Biosciences Q1 Results Gufic Biosciences Q2 Results Gufic Biosciences Q3 Results Gufic Biosciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks